Schrödinger said it is ending development of the CHC7 inhibitor in blood cancer as both a monotherapy and combination.

Remegen's Telitacicept met its primary endpoints in a Chinese trial, while a US-based Phase III trial in Sjögren's syndrome ...

Aligos has initiated dosing in the Phase II B-SUPREME trial of its ALG-000184 in people with chronic hepatitis B virus (HBV) ...

CuraCell Holding’s CTA has received approval from Germany's Paul-Ehrlich-Institut (PEI) to begin a Phase I/IIa trial of CC-38 ...

Vendanta's CEO also announced the company is cutting 20% of its workforce as a result of the Phase II UC trial failure.

The close relationship between gastroparesis and diabetes makes this condition a significant public health concern.